BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30821201)

  • 1. Dynamically borrowing strength from another study through shrinkage estimation.
    Röver C; Friede T
    Stat Methods Med Res; 2020 Jan; 29(1):293-308. PubMed ID: 30821201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bounds for the weight of external data in shrinkage estimation.
    Röver C; Friede T
    Biom J; 2021 Jun; 63(5):1131-1143. PubMed ID: 33629749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of few small studies in orphan diseases.
    Friede T; Röver C; Wandel S; Neuenschwander B
    Res Synth Methods; 2017 Mar; 8(1):79-91. PubMed ID: 27362487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Bayesian meta-analytic approach for safety signal detection in randomized clinical trials.
    Odani M; Fukimbara S; Sato T
    Clin Trials; 2017 Apr; 14(2):192-200. PubMed ID: 28059578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borrowing strength from external trials in a meta-analysis.
    Higgins JP; Whitehead A
    Stat Med; 1996 Dec; 15(24):2733-49. PubMed ID: 8981683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bayesian basket trial design using a calibrated Bayesian hierarchical model.
    Chu Y; Yuan Y
    Clin Trials; 2018 Apr; 15(2):149-158. PubMed ID: 29499621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a random effects meta-analysis in the design and analysis of a new clinical trial.
    Jones HE; Ades AE; Sutton AJ; Welton NJ
    Stat Med; 2018 Dec; 37(30):4665-4679. PubMed ID: 30187505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Bayesian hierarchical model for high-dimensional meta-analysis.
    Liu F
    Methods Mol Biol; 2010; 620():538-46. PubMed ID: 20652520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alone, together: On the benefits of Bayesian borrowing in a meta-analytic setting.
    Harari O; Soltanifar M; Verhoek A; Heeg B
    Pharm Stat; 2023; 22(5):903-920. PubMed ID: 37321565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Random-effects meta-analysis of few studies involving rare events.
    Günhan BK; Röver C; Friede T
    Res Synth Methods; 2020 Jan; 11(1):74-90. PubMed ID: 31348846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On weakly informative prior distributions for the heterogeneity parameter in Bayesian random-effects meta-analysis.
    Röver C; Bender R; Dias S; Schmid CH; Schmidli H; Sturtz S; Weber S; Friede T
    Res Synth Methods; 2021 Jul; 12(4):448-474. PubMed ID: 33486828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addressing statistical issues when leveraging external control data in pediatric clinical trials using Bayesian dynamic borrowing.
    Spanakis E; Kron M; Bereswill M; Mukhopadhyay S
    J Biopharm Stat; 2023 Nov; 33(6):752-769. PubMed ID: 36507718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust meta-analytic-predictive priors in clinical trials with historical control information.
    Schmidli H; Gsteiger S; Roychoudhury S; O'Hagan A; Spiegelhalter D; Neuenschwander B
    Biometrics; 2014 Dec; 70(4):1023-32. PubMed ID: 25355546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis.
    Turner RM; Jackson D; Wei Y; Thompson SG; Higgins JP
    Stat Med; 2015 Mar; 34(6):984-98. PubMed ID: 25475839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Empirical Bayes estimation of the selected treatment mean for two-stage drop-the-loser trials: a meta-analytic approach.
    Bowden J; Brannath W; Glimm E
    Stat Med; 2014 Feb; 33(3):388-400. PubMed ID: 23873666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bayesian Design for Pediatric Clinical Trials with Binary Endpoints When Borrowing Historical Information of Treatment Effect.
    Jin M; Li Q; Kaur A
    Ther Innov Regul Sci; 2021 Mar; 55(2):360-369. PubMed ID: 32955713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of continuous outcome data from individual patients.
    Higgins JP; Whitehead A; Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Aug; 20(15):2219-41. PubMed ID: 11468761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian hypothesis testing and estimation under the marginalized random-effects meta-analysis model.
    van Aert RCM; Mulder J
    Psychon Bull Rev; 2022 Feb; 29(1):55-69. PubMed ID: 34159526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.